期刊名称:QSAR & COMBINATORIAL SCIENCE
|
ISSN: | 1611-020X
|
|
出版频率: | Monthly
|
|
出版社: | WILEY-V C H VERLAG GMBH, PO BOX 10 11 61, WEINHEIM, GERMANY, D-69451
|
|
期刊网址: | http://www3.interscience.wiley.com/cgi-bin/jhome/104557877?CRETRY=1&SRETRY=0
| |
影响因子: | 2.594(2008) |
| 主题范畴: | PHARMACOLOGY & PHARMACY; COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS; CHEMISTRY, MULTIDISCIPLINARY; CHEMISTRY, MEDICINAL |
| 变更情况: | 2010年起刊名变更为Molecular Informatics(ISSN:1868-1743 ) |
期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
With the support of the QSAR and Modelling Society and the Society of Combinatorial Sciences a dedicated team of editors has started the journal QSAR & Combinatorial Science which is replacing the former Quantitative Structure-Activity Relationships. QSAR & Combinatorial Science is now the international forum covering high-quality results on all aspects of computer-assisted methods and combinatorial techniques, as well as their applications in organic and inorganic chemistry, medicinal chemistry, biochemistry, drug design, and materials science. One of the most important and popular features continues to be the QSAR Abstracting Service, a service exclusive to this journal.
Special Issues in 2006:
- Multicomponent Chemistry
- Fluorous Synthesis
- Challenges in Virtual Screening
- Array Synthesis
Readership
Medicinal chemists, organic chemists, biochemists, toxicologists, pharmacologists, drug designers
Instructions to Authors 1611-020X.pdf
Editorial Board
Editorial Advisory Board
Dimitris K. Agrafiotis, Johnson & Johnson, PA, USA
Karl-Heinz Baringhaus, Sanofi–Aventis, Frankfurt, Germany
Scott Boyer, AstraZeneca, Mölndal, Sweden
Mark T. Cronin, Liverpool John Moores University, UK
Peter Ertl, Novartis, Basel, Switzerland
Kimito Funatsu, The University of Tokyo, Japan
Robert Glen, University of Cambridge, UK
Andrew C. Good, Genzyme Corporation, Framingham, MA, USA
Paola Gramatica, University of Insubria, Varese, Italy
Wolfgang Guba, F. Hoffmann-La Roche, Basel, Switzerland
Philip J. Hadjuk, Abott Laboratories, Abbott Park, USA
Donald Hilvert, ETH Zürich, Switzerland
Andrew L. Hopkins, University of Dundee, UK
Ad P. IJzerman, Universiteit Leiden, The Netherlands
Hualiang Jiang, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Pudong, Shanghai, China
Dmitry A. Konovalov, James Cook University, Townsville, Australia
Muthukumarasamy Karthikeyan, National Chemical Laboratory, Pune, India
David Lloyd, Trinity College Dublin, Ireland
David Manallack, Monash University, Melbourne, Australia
Jonathan S. Mason, Lundbeck Research, Copenhagen, Denmark
Stefano Moro, Università degli Studi di Padova, Italy
Ingo Mügge, Böhringer Ingelheim, Ridgefield, CT, USA
Tudor I. Oprea, University of New Mexico, Albuquerque, USA
John P. Overington, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK
Stephen D. Pickett, GlaxoSmithKline, Hertfordshire, UK
Brian K. Shoichet, University of California, San Francisco, USA
Sung-Sau So, F. Hoffmann-La Roche, New Jersey, USA
Michael J. E. Sternberg, Imperial College London, UK
Igor V. Tetko, Helmholtz-Zentrum Neuherberg, Germany
Alexander Tropsha, University of North Carolina, Chapel Hill, USA
Alexandre Varnek, Université de Strasbourg, France
Patrick Walters, Vertex Pharmaceuticals, Cambridge, MA, USA
Renxiao Wang, Chinese Academy of Sciences, Shanghai, China
Tanja Weil, National University of Singapore
Jianhua Yao, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, China
|